Posted by Michael Wonder on 28 Sep 2021
Lilly again reduces list price of insulin lispro Injection as latest change to affordability options
28 September 2021 - Lilly's insulin lispro injection -- first introduced at half the list price of branded Humalog in 2019 will now have a 70% lower list price.
Eli Lilly will lower the list price of Insulin Lispro Injection in the U.S. by an additional 40% effective 1 January 2022, effectively bringing the list price down to 2008 levels.
The new list price will apply to all Lilly's non-branded insulins, including Insulin Lispro Injection, a lower list-priced alternative to Humalog U-100.
